Skip to content

M&A

Sichenzia Ross Ference Carmel LLP 代表 Sharps Technology, Inc. 完成 350 万美元过桥融资

September 25, 2024

Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $3.5 Million Bridge Financing

September 25, 2024

Sichenzia Ross Ference Carmel LLP Represents Kaival Brands Innovations Group, Inc. in Definitive Merger and Share Exchange Agreement with Delta Corp Holdings Limited

September 24, 2024

Sichenzia Ross Ference Carmel LLP Represents Elevai Labs, Inc. in Pricing of $8.0 Million Public Offering

September 23, 2024

Sichenzia Ross Ference Carmel LLP Represents Impact Biomedical Inc. in Closing of $4.5 Million Initial Public Offering

September 18, 2024

Sichenzia Ross Ference Carmel LLP Represents Tenon Medical Inc. in a $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

September 17, 2024

Sichenzia Ross Ference Carmel LLP Represents Vuzix Corporation in $20 million Private Placement Offering with Strategic Investor

September 16, 2024

Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $8.5 Million Offering

September 13, 2024

September 12, 2024

Sichenzia Ross Ference Carmel LLP Represents NuZee, Inc. in Two PIPE Transactions Totaling $4.3 Million

September 12, 2024

Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital LLC and Revere Securities LLC in the $9 Million Initial Public Offering of Trident Digital Tech Holdings Ltd.

September 11, 2024

Sichenzia Ross Ference Carmel LLP Represents EF Hutton in the $4 Million Private Placement of Solidion Technology, Inc.

September 9, 2024

Sichenzia Ross Ference Carmel LLP Represents Joseph Gunnar & Co., LLC in $0.4 Million Registered Direct Offering of Eastside Distilling

September 6, 2024

Sichenzia Ross Ference Carmel LLP Represents Qualigen Therapeutics, Inc. in $3.47 Million Public Offering

September 6, 2024

Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharmaceuticals, Inc. in $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

September 6, 2024

Sichenzia Ross Ference Carmel LLP represents Virax Biolabs Group Limited in a $5 Million Registered Direct Offering

August 30, 2024

Sichenzia Ross Ference Carmel LLP Represents Wilson-Davis & Co., Inc. in $11.25 Million Initial Public Offering of Ordinary Shares of JBDI Holdings Limited

August 30, 2024

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $20 Million PIPE and Warrant Exercise of Uber and NVIDIA-backed Serve Robotics Inc.

August 30, 2024

Sichenzia Ross Ference Carmel LLP Represents Cathay Securities, Inc. in the $8.5 million IPO of Reitar Logtech Holdings Limited

August 27, 2024

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in a $4.4 Million Private Placement of Jones Soda Co.

August 26, 2024

Sichenzia Ross Ference Carmel LLP represents EF Hutton LLC in a $2.9 Million Public Offering of New Horizon Aircraft

August 22, 2024